Trade Mark Journal No.2026/045 6 November 2026

WO0000001937970 (5)

Office of origin: United States of America

Date of International Registration:17 August 2026
Date of designation in the UK: 17 September 2026
Image for mark 1937970 TUHIBRIA

International priority date claimed: 30 June 2026 (United States of America) (99914976)
Class 5
Pharmaceutical preparations for the treatment and prevention of hypertrophic cardiomyopathy.

Lexicon Pharmaceuticals, Inc.

Representative: Tania Shapiro-Barr Viksnins Harris Padys Malen LLP, 7900 International Drive,, Suite 410, Bloomington MN 55425, UNITED STATES OF AMERICA